Frontotemporal Dementia
📧 Sign up to get email alerts when something new happens for Frontotemporal Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Communication Bridge Speech Therapy Research Study [NA]
A completed clinical trial evaluating the Communication Bridge speech therapy program for Primary Progressive Aphasia and Frontotemporal Dem…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
A clinical trial update evaluating progression markers in neurodegenerative diseases, including Parkinson's disease, currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
The University of Massachusetts Worcester-sponsored genetic study on familial and sporadic amyotrophic lateral sclerosis/motor neuron diseas…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Effects of Tolcapone on Frontotemporal Dementia [Phase 2]
Phase 2 trial evaluating tolcapone for Frontotemporal dementia has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of VES001 in healthy participants has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Longitudinal Cognitive Assessment by BoCA
Clinical trial update for BoCA, a longitudinal cognitive assessment tool, with ongoing recruitment for Alzheimer's disease and mild cognitiv…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: The Healthy Patterns Sleep Study [Phase 3]
Healthy Patterns Sleep Study Phase 3 has completed, and its results were posted in 2024, evaluating sleep and circadian patterns in dementia…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research [NA]
A completed clinical trial evaluating a relational recruitment and engagement intervention for cognitive aging research; results were posted…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Intranasal Oxytocin for Frontotemporal Dementia [Phase 2]
Phase 2 clinical trial evaluating intranasal oxytocin for frontotemporal dementia is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Intranasal Insulin in Frontotemporal Dementia (FTD) [Phase 2]
Phase 2 trial of intranasal insulin for frontotemporal dementia (behavioral variant) was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy [Phase 2]
A Phase 2 clinical trial investigating the influence of vascular burden, amyloid plaque, and tau protein in patients with vascular cognitive…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Therapy in Amyotrophic Lateral Sclerosis (TAME) [Phase 2]
Phase 2 trial update for a therapy in amyotrophic lateral sclerosis and frontotemporal dementia; trial completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: In-Home Technology for Dementia Caregivers [NA]
A completed clinical trial from UC Berkeley examined in-home technology for dementia caregivers, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Flortaucipir PET Imaging in Subjects With FTD [Phase 1]
Phase 1 trial updating Flortaucipir PET imaging in subjects with Frontotemporal Dementia has completed with results posted.
-
CLINICAL_TRIALS research · 2019-12-06Clinical Trial Update: Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations [Phase 2]
Phase 2 study evaluating tau PET imaging with 18F-AV-1451 in individuals with MAPT mutations completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia [NA]
Completed clinical trial evaluating web-based social-cognitive interventions for right hemisphere stroke and frontotemporal dementia, with r…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia [Phase 2]
Phase 2 trial update investigating the impact of emotional mimicry and oxytocin on frontotemporal dementia has been completed.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Living With Frontotemporal Dementia
An NHGRI-sponsored clinical trial on adaptation for people living with frontotemporal dementia has been terminated.
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: Identification of New FTLD Genes
Clinical trial update focusing on identifying new genetic contributors to frontotemporal dementia (FTLD).
-
CLINICAL_TRIALS withdrawal · 2017-08-14Clinical Trial Update: Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) [Phase 4]
This Phase 4 trial of amantadine for behavioral disturbance in Frontotemporal dementia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Double Blind Trial of DC Polarization in FTD [Phase 2]
A completed Phase 2 double-blind trial evaluating DC polarization as a treatment for frontotemporal dementia.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Treatment Study of Frontotemporal Dementia
This clinical trial update from the National Institute of Neurological Disorders and Stroke describes a treatment study for frontotemporal d…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia [Phase 4]
Phase 4 study investigating serotonergic function and behavioural and psychological symptoms in frontotemporal dementia has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Computational Tools for Early Diagnosis of Memory Disorders
The trial update reports completion of a University of Eastern Finland–led study evaluating computational tools for early diagnosis of memor…
-
CLINICAL_TRIALS research · 2016-12-16Clinical Trial Update: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects [Phase 1]
Phase 1 study evaluating the PET tracer [18F]MNI-777 as a marker of tau pathology in tauopathy subjects and healthy controls has been comple…